Abhijat Kitchlu Selected Research

Therapeutics

11/2021	Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study.
9/2021	Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review.
3/2021	CKD After 225Ac-PSMA617 Therapy in Patients With Metastatic Prostate Cancer.
1/2021	Conventional Chemotherapy Nephrotoxicity.
1/2021	Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature.
1/2021	A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease.
1/2021	Defining cisplatin eligibility in patients with muscle-invasive bladder cancer.
1/2020	Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
1/2020	Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes.
1/2020	Perspectives From an Onconephrology Interest Group: Conference Report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abhijat Kitchlu Research Topics

Disease

17	Neoplasms (Cancer) 02/2022 - 10/2017
14	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 05/2011
6	Chronic Renal Insufficiency 11/2021 - 04/2014
3	Critical Illness (Critically Ill) 01/2021 - 04/2014
2	Proteinuria 05/2022 - 10/2017
2	Thrombotic Microangiopathies 05/2022 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 09/2021 - 01/2021
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021 - 01/2020
2	Kidney Neoplasms (Kidney Cancer) 01/2021 - 01/2020
2	Hyponatremia 01/2020 - 01/2019
1	Hypertension (High Blood Pressure) 05/2022
1	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2022
1	Skin Neoplasms (Skin Cancer) 02/2022
1	Hematologic Diseases (Blood Diseases) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2021
1	Atrial Fibrillation 10/2021
1	Prostatic Neoplasms (Prostate Cancer) 03/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Glomerulonephritis 01/2021
1	Infections 01/2021
1	Ketosis 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Disease Progression 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Tumor Lysis Syndrome 01/2020
1	Amyloidosis 01/2020
1	Amyloid Plaque 01/2020
1	Paraproteinemias (Monoclonal Gammopathy) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Heart Failure 01/2020
1	Testicular Neoplasms (Testicular Cancer) 10/2019
1	Lymphoma (Lymphomas) 06/2019
1	Melanoma (Melanoma, Malignant) 10/2017
1	Hodgkin Disease (Hodgkin's Disease) 10/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2017
1	Autosomal Dominant Polycystic Kidney (ADPKD) 06/2017
1	Venous Thromboembolism 05/2015

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2020
5	CreatinineIBA 05/2022 - 10/2019
4	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 06/2019
3	ElectrolytesIBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 05/2022 - 10/2019
2	SodiumIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2017
2	SteroidsIBA 01/2020 - 05/2015
1	liposomal doxorubicin (Doxil)FDA Link 05/2022
1	Dabigatran FDA Link 10/2021
1	apixabanIBA 10/2021
1	Warfarin (Coumadin)FDA LinkGeneric 10/2021
1	AnticoagulantsIBA 10/2021
1	RivaroxabanIBA 10/2021
1	AntibodiesIBA 09/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Complement C3 (C3 Complement)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Angiogenesis InhibitorsIBA 01/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Prealbumin (Transthyretin)IBA 01/2020
1	MagnesiumIBA 06/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 06/2019
1	Vasopressins (Vasopressin)IBA 01/2019
1	DiureticsIBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Vitamin K FDA Link 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	pembrolizumabIBA 10/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017
1	CTLA-4 AntigenIBA 10/2017
1	IpilimumabIBA 10/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2011

Therapy/Procedure

16	Therapeutics 11/2021 - 06/2017
4	Kidney Transplantation 05/2022 - 01/2018
3	Continuous Renal Replacement Therapy 01/2021 - 04/2014
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
2	Transplantation 02/2022 - 01/2021
2	Organ Transplantation 02/2022 - 01/2021
2	Hybrid Renal Replacement Therapy 01/2021 - 08/2015
1	Aftercare (After-Treatment) 05/2022
1	Cell Transplantation 01/2022
1	Nephrectomy 01/2021
1	Neoadjuvant Therapy 01/2021
1	Home Nursing (Nursing, Home) 01/2018
1	Immunotherapy 10/2017
1	Patient Readmission 01/2017
1	Respiratory Therapy (Therapy, Respiratory) 05/2015
1	Renal Dialysis (Hemodialysis) 04/2014
1	Artificial Respiration (Mechanical Ventilation) 04/2014
1	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2014